Sabby Management, LLC Context Therapeutics Inc. Transaction History

Sabby Management, LLC

  • $130,000
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.29 - $2.66 $1.5 Million - $3.1 Million
-1,165,100 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$1.72 - $2.82 $113,055 - $185,358
-65,730 Reduced 5.34%
1,165,100 $2.53 Million
Q4 2021

Feb 14, 2022
BUY
$2.66 - $7.45 $3.27 Million - $9.17 Million
1,230,830 New
1,230,830 $3.27 Million

Others Institutions Holding CNTX

# of Institutions
45
Shares Held
56.9M
Call Options Held
0
Put Options Held
0
View Full List

About Context Therapeutics Inc.

CNTX Quotes by TradingView
  • Ticker CNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,966,100
  • Market Cap $18M
  • Description
  • Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...
More about CNTX
Track This Portfolio

Track Sabby Management, LLC Portfolio

Follow Sabby Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sabby Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email